首页 › 基金 › Knoll Capital Management, LLC › PHAR

Knoll Capital Management, LLC 对 PHAR 的持仓历史

Pharming Group NV · 医疗保健

Knoll Capital Management, LLC 在 Q3 2026 的 13F 申报中披露持有 PHAR(Pharming Group NV)4,091 股,市值约 US$41K,约占其申报组合的 0.02%,在其申报持仓中市值排名第 36 位。 Knoll Capital Management, LLC 最近 3 个申报季度中有 3 个季度披露了 PHAR 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)4.09K 股
申报持仓市值$40.87K
组合权重0.02%
首次申报Q1 2026
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Knoll Capital Management, LLC 对 PHAR 的持仓演变

Knoll Capital Management, LLC 于 Q1 2026 首次披露 PHAR 持仓:4,057 股(约 US$68K)。 在 3 次申报中,Knoll Capital Management, LLC 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 4,091 股、市值约 US$41K。

逐季持仓明细

季度股数金额变化
Q1 2026 4.06K $67.51K 新进
Q2 2026 4.09K $56.82K 增持
Q3 2026 4.09K $40.87K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 PHAR 与 13F 数据

PHAR(Pharming Group NV)属于医疗保健行业。我们追踪的基金中还有 10 只申报持有 PHAR,申报仓位最大的包括:Silverberg Bernstein Capital Management LLC (US$358K)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 PHAR 的基金

查看 PHAR 的全部基金持有人 →

常见问题

How long has Knoll Capital Management, LLC held PHAR?

Knoll Capital Management, LLC has disclosed PHAR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Knoll Capital Management, LLC's current position in PHAR?

As of Q3 2026, Knoll Capital Management, LLC holds 4.09K shares of PHAR (Pharming Group NV), valued at $40.87K, representing 0.02% of its reported portfolio and ranking #36.

Has Knoll Capital Management, LLC been buying or selling PHAR?

In the latest 13F filing (Q3 2026), Knoll Capital Management, LLC held unchanged its position in PHAR.

Which other funds hold PHAR?

Other major institutional holders of PHAR include Silverberg Bernstein Capital Management LLC, among 10 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.